IMAGE

Fig. 1

ID
ZDB-IMAGE-101119-24
Source
Figures for Cao et al., 2009
Image
Figure Caption

Fig. 1

Suppression of pkd2 mutants/morphants by TSA. (A and B) Treatment of 500 nM TSA from the shield stage leads to slight ventral curvature (B) on 2 dpf in wild-type embryos (wt) as compared to embryos treated with DMSO (A). (C–E) TSA can suppress the body curvature of pkd2/hi4166 mutant embryos. (C) shows mutant embryos treated with DMSO from 27 hpf on 2 dpf. Red lines depict the definition of curvature angle. (D) shows embryos treated with 500 nM TSA from 27 hpf on 2 dpf. With this treatment, mutant embryos are indistinguishable from wild-type siblings. (E) Average curvature angle in embryos treated with DMSO, 200 and 500 nM TSA. n = 5, *, P < 0.05, **, P < 0.0005. (F–H) Inhibition of kidney cyst formation in pkd2 morphants (pkd2mo) on 3 dpf by treatment of 100 nm TSA from the bud stage. (F) shows a pkd2 morphants treated with DMSO. The arrow points to the cyst. (F) shows a morphant treated with TSA. Insets show kidney cyst in F or the lack of cyst in G. (H) Average of percentage of embryos with kidney cysts from 3 independent experiments. Twenty-five to fifty embryos were examined in each experiment. ***, P < 0.005.

Figure Data
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Proc. Natl. Acad. Sci. USA